New drug combo tested to stop advanced throat cancer from spreading
NCT ID NCT02973386
Summary
This study tested whether adding a chemotherapy drug called capecitabine after standard chemoradiation treatment could better control advanced nasopharyngeal cancer and prevent it from spreading to other parts of the body. Researchers compared two groups of patients: one receiving the standard treatment alone and another receiving the standard treatment plus the additional drug. The goal was to find a more effective treatment approach with manageable side effects for patients at high risk of their cancer spreading.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCAL ADVANCED HIGH RISK NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.